Novel Clinical Prognostic Stage Group System for Prostate Cancer

Description

The international staging collaboration for prostate cancer (STAR-CAP) proposes a new pretreatment, predictive staging system for nonmetastatic prostate cancer. This staging classification system is based on competing-risk regression statistical modeling. It may be used to predict the risk of prostate cancer–specific mortality for a diverse cohort of men diagnosed with clinically localized prostate cancer. This cohort study was published by Robert T. Dess, MD, of the University of Michigan School of Medicine, Ann Arbor, and colleagues in JAMA Oncology.